Accuray (ARAY) Competitors

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.

Which has more risk and volatility, ARAY or OFIX?

Accuray has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500.

Which has higher valuation & earnings, ARAY or OFIX?

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accuray	$453.14M	0.38	-$15.55M	-$0.05	-33.80
Orthofix Medical	$799.49M	0.76	-$151.40M	-$3.29	-4.72

Does the MarketBeat Community believe in ARAY or OFIX?

Orthofix Medical received 83 more outperform votes than Accuray when rated by MarketBeat users. However, 65.56% of users gave Accuray an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
Accuray	Outperform Votes 335 65.56%	Underperform Votes 176 34.44%
Orthofix Medical	Outperform Votes 418 62.20%	Underperform Votes 254 37.80%

Do institutionals & insiders hold more shares of ARAY or OFIX?

64.1% of Accuray shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 4.2% of Accuray shares are held by company insiders. Comparatively, 2.6% of Orthofix Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Do analysts rate ARAY or OFIX?

Orthofix Medical has a consensus price target of $23.33, indicating a potential upside of 50.15%. Given Orthofix Medical's stronger consensus rating and higher probable upside, analysts plainly believe Orthofix Medical is more favorable than Accuray.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accuray	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Orthofix Medical	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Is ARAY or OFIX more profitable?

Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accuray	-0.96%	-9.75%	-0.93%
Orthofix Medical	-15.18%	-21.25%	-13.29%

Does the media refer more to ARAY or OFIX?

In the previous week, Accuray had 2 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Accuray and 1 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.46 beat Accuray's score of 0.45 indicating that Orthofix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accuray	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Orthofix Medical	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Accuray and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks.